Geistlich Pharma specialises in biomaterials for the regeneration of bone, cartilage and tissue. The information provided on Facebook is general in nature.
Geistlich Biomaterials specialises in biomaterials for the regeneration of bone, cartilage and tissue and has been a leader in regenerative medicine for over 30 years. Geistlich Biomaterials belongs to Geistlich Pharma AG, a family-owned company with experience in bone and tissue processing since 1851. Geistlich Pharma does not practice medicine or provide medical services or advice and the information on this account should not be considered medical advice. Patients are invited to visit www.geistlich-pharma.com/patients/ for further information.
14/11/2025
Preserve what matters most.
Professor Axel Spahr explains how the abutment free design of the TRI® matrix® implant supports a thicker, healthier soft-tissue seal - helping maintain long-term peri-implant stability and reduce the risk of peri-implantitis.
.dental.anz
10/11/2025
Professor Axel Spahr answers - What TRI® matrix® feature do you believe most supports long term tissue health?
.dental.anz
10/11/2025
We’re delighted to welcome Tess to the Geistlich ANZ team!
Tess joins us as our new Product Specialist for Queensland, bringing over 25 years of experience - including 12 years in the dental sector across Australia and New Zealand.
With a strong clinical background and deep understanding of digital workflows, Tess is passionate about helping clinicians achieve predictable, reliable results.
09/11/2025
Don't forget to Bundle and Save!
For a limited time buy Pocket-X® Gel and get 30% off the stoma® Prophylaxis Kit!
🎁 Every order includes a FREE Geistlich Tote Bag!
🗓️ Available until 30 Nov 2025
Use the code BUNDLE-STO30 on the E-Shop and save big today!
A fantastic morning with ADA Victoria and Dr Luan Ngo for the Periodontal Soft Tissue Surgery and Grafting workshop.
An excellent hands-on session exploring surgical techniques, grafting materials, and suturing approaches for both teeth and implant sites.
We’re proud to support ongoing education that advances patient care.
29/10/2025
✨ 3 Questions, 3 Voices ✨
“Go to the literature. Don’t learn the hard way.”
Dr Greg Peake’s advice for young clinicians: choose biomaterials that are reliable, predictable, and scientifically proven — and if your rep can’t show you the evidence, find a new one.
▶️ Watch the full Cheap vs Proven debate on-demand to access your CPD certificate and download the GBR Confidence Checklist: go to geistlich-anz.live
28/10/2025
✨ 3 Questions, 3 Voices ✨
“Do your research. Know your tools.”
Dr Ashi Singh shares her advice for young clinicians on choosing biomaterials — why understanding the biological pathway leads to better outcomes.
▶️ Watch the full Cheap vs Proven debate on-demand to access your CPD certificate and download the GBR Confidence Checklist: go to geistlich-anz.live
27/10/2025
A huge thank you to .nikosmattheos for sharing his insights at the 3rd Geistlich Australasian Symposium.
From patient selection, to digital workflows and AI, his perspective reminds us how much precision, empathy, and innovation shape long-term aesthetic success in implant dentistry.
Be the first to know and let us send you an email when Geistlich Australia & New Zealand posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Geistlich Australia & New Zealand:
Geistlich Biomaterials has been specialised in regenerative medicine for over 30 years.
With its pioneer products, Geistlich Bio-Oss® and Geistlich Bio-Gide® the company has been the worldwide market leader in regenerative dentistry for many years.
Geistlich Biomaterials belongs to Geistlich Pharma AG, a family-owned company with experience in bone and tissue processing since 1851.
The headquarters is based in Switzerland where Geistlich also produces its biomaterials in its own production.
Geistlich Pharma Australia is based in Sydney and is the local affiliate to supply and serve dental clinicians in the field of oral hard and soft-tissue regeneration throughout Australia, New Zealand and the Pacific region.